首页> 外文期刊>Progress in Neuro-Psychopharmacology & Biological Psychiatry: An International Research, Review and News Journal >N-Methyl-D-aspartate receptor in working memory impairments in schizophrenia: event-related potential study of late stage of working memory process.
【24h】

N-Methyl-D-aspartate receptor in working memory impairments in schizophrenia: event-related potential study of late stage of working memory process.

机译:N-甲基-D-天冬氨酸受体在精神分裂症的工作记忆障碍中的作用:工作记忆过程后期阶段的事件相关电位研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Working memory (WM) deficit in schizophrenic patients has been well established. Still, underlying biological substrate of the impairment is not clear. Among neurotransmitter hypotheses of schizophrenia, N-methyl-D-aspartate (NMDA) receptor model is mostly supported, considering that NMDA receptor antagonist can elicit both psychosis and cognitive impairment observed in schizophrenic patients. In current study, to test the neuropsychological and the electrophysiological effects of NMDA receptor in WM, event-related potentials (ERPs) of Sternberg's short-term memory scanning task (SMST) were analyzed in 10 healthy subjects under intravenous administration of a subanesthetic dose of ketamine (0.65 mg/kg/h) or placebo (normal saline). Late positive component (LPC) of ERP was hypothesized to reflect later stage of WM. Brief Psychiatric Rating Scale score was significantly increased (t=-5.75, df=9, P<.001) and correct response rate was significantly decreased (t=2.21, df=9, P=.054) after ketamine administration. Neither reaction time nor LPC latency, which reflect memory scanning time, was changed. Amplitude of LPC was significantly reduced after ketamine administration (z=-2.31, number of observations=120, P=.021). In conclusion, NMDA receptor antagonist administration elicited WM deficit both in behavioral and electrophysiological level. Electrophysiological component reflecting later stage of WM was impaired by NMDA antagonist.
机译:精神分裂症患者的工作记忆(WM)缺陷已得到充分证实。尚不清楚该损伤的潜在生物学底物。在精神分裂症的神经递质假说中,考虑到NMDA受体拮抗剂可引起精神分裂症患者的精神病和认知障碍,因此大多数支持N-甲基-D-天冬氨酸(NMDA)受体模型。在当前的研究中,为测试NMDA受体在WM中的神经心理学和电生理作用,在10例健康受试者静脉注射亚麻醉剂量的10例健康受试者中,分析了Sternberg的短期记忆扫描任务(SMST)的事件相关电位(ERP)。氯胺酮(0.65 mg / kg / h)或安慰剂(生理盐水)。假设ERP的晚期阳性成分(LPC)反映了WM的后期。氯胺酮给药后,简短的精神病学评定量表评分显着提高(t = -5.75,df = 9,P <.001),正确的缓解率显着降低(t = 2.21,df = 9,P = .054)。反映内存扫描时间的反应时间和LPC延迟都没有改变。氯胺酮给药后LPC的幅度显着降低(z = -2.31,观察次数= 120,P = .021)。最后,NMDA受体拮抗剂的使用引起行为和电生理水平的WM缺陷。 NMDA拮抗剂损害了反映WM晚期的电生理成分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号